Article
Plasma DYRK1A as a novel risk factor for Alzheimer’s disease
12 Aug 2014
Abstract excerpt
To determine whether apparent involvement of DYRK1A in Alzheimer's disease (AD) pathology makes it a candidate plasma biomarker for diagnosis, we developed a method to quantify plasma DYRK1A by immunoblot in transgenic mouse models having different gene dosages of Dyrk1a, and, consequently, different relative protein expression. Then, we measured plasma DYRK1A levels in 26 patients with biologically confirmed AD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
